Overcoming the physiological barriers in the eye remains a key obstacle in the field of ocular
drug delivery. While ocular barriers naturally have a protective function, they also limit drug …

Administration of drugs through oral and intravenous routes is a mainstay of modern
medicine, but this approach suffers from limitations associated with off-target side effects and …

Dendrimers are biocompatible organic nanomaterials with unique physicochemical
properties, making them the focus of recent research in drug delivery. The cornea of the …

Corneal disease remains a leading cause of impaired vision world-wide, and advancements
in gene therapy continue to develop with promising success to prevent, treat and cure …

Introduction: Drug delivery to the back of the eye requires strategic approaches that
guarantee the long-term therapeutic effect with patient compliance. Current treatments for …

Optimal vision remains one of the most essential elements of the sensory system
continuously threatened by many ocular pathologies. Various pharmacological agents …

In this review, we present current state-of-the-art developments and challenges in the areas
of thermal therapy, ultrasound tomography, image-guided therapies, ocular drug delivery …

Introduction: Due to numerous anatomical and physiological barriers, ocular drug delivery
remains a major limitation in the treatment of diseases such as glaucoma, macular …

Purpose: Delivery of sufficient amounts of therapeutic drugs into the eye for treatment of
various ocular diseases is often a challenging task. Ultrasound was shown to be effective in …

Topical corticosteroids are the primary treatment of ocular inflammation caused by surgery,
injury, or other conditions. Drug pre-corneal residence time, drug water solubility, and drug …